The poultry vaccines market focuses on the development, production, and distribution of vaccines used to prevent infectious diseases in poultry such as chickens, ducks, and turkeys. These vaccines help protect against viral, bacterial, and parasitic infections, including Newcastle disease, avian influenza, Marek’s disease, and infectious bronchitis. Vaccination plays a critical role in maintaining flock health, improving productivity, and ensuring food safety in the poultry industry. Market growth is driven by the rising global demand for poultry meat and eggs, increasing disease outbreaks among poultry populations, and growing awareness about animal health and biosecurity. Advances in biotechnology—such as recombinant vaccines, vector-based vaccines, and combination formulations—are enhancing vaccine efficacy and convenience for farmers.
According to Fortune Business Insights, the poultry vaccines market share was valued at USD 1.27 billion in 2024 and is projected to grow from USD 1.32 billion in 2025 to USD 2.01 billion by 2032, exhibiting a CAGR of 6.13% during the forecast period. North America dominated the market, accounting for a 45.66% share in 2024.
The report covers global industry performance, size, share, growth forecasts, segmentation by vaccine type, technology, application (breeder, layer, broiler), disease indication, route of administration, and regional breakdown. It includes analysis of the competitive landscape, key company strategies, product launches, and emerging trends shaping future growth.